Advertisement
Screener

DocGo Inc. (DCGO) Overview

DocGo Inc. (DCGO) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.16; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.15; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.28; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.11; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$0.24$0.32$0.45$0.61$0.85$1.172025-11-062026-11-06$0.24$0.51$1.12$2.45$5.34$11.652021-11-082026-11-06$0.24$0.51$1.12$2.45$5.34$11.652020-12-172026-11-06$0.24$0.51$1.12$2.45$5.34$11.652020-12-172026-11-06$0.24$0.51$1.12$2.45$5.34$11.652020-12-172026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$0.25
Previous close
$0.37
Change
-$0.12
Change (%)
-32.72%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

DCGO
-58.69%
S&P 500
(m)

1 year

DCGO
-73.65%
S&P 500
(m)

3 years

DCGO
-93.18%
S&P 500
(m)

5 years

DCGO
-96.35%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.16

-0.36-0.25-0.14-0.020.0931 Mar 2025: estimate (m); actual -0.0931 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.1130 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.2830 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.1531 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.1630 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.16(m)(m)
1 Jan 202631 Mar 2026(m)-0.15(m)(m)
1 Jul 202530 Sept 2025(m)-0.28(m)(m)
1 Apr 202530 Jun 2025(m)-0.11(m)(m)
1 Jan 202531 Mar 2025(m)-0.09(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -1.84

-1.92-1.31-0.70-0.090.5231 Dec 2021: estimate (m); actual 0.2531 Dec 2021(m)31 Dec 2022: estimate (m); actual 0.3431 Dec 2022(m)31 Dec 2023: estimate (m); actual 0.0631 Dec 2023(m)31 Dec 2024: estimate (m); actual 0.1831 Dec 2024(m)31 Dec 2025: estimate (m); actual -1.8431 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-1.84(m)(m)
1 Jan 202431 Dec 2024(m)0.18(m)(m)
1 Jan 202331 Dec 2023(m)0.06(m)(m)
1 Jan 202231 Dec 2022(m)0.34(m)(m)
1 Jan 202131 Dec 2021(m)0.25(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 73.42M ■ Earnings -15.82M — Profit margin -21.55%

-174.87M-198.6%-82.45M-138.5%9.96M-78.5%102.38M-18.5%30 Sept 2025: revenue 70.81M; earnings -27.77M; profit margin -39.22%30 Sept 202531 Dec 2025: revenue 74.94M*; earnings -148.04M*; profit margin -197.55%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 75.55M; earnings -14.76M; profit margin -19.54%31 Mar 202630 Jun 2026: revenue 73.42M; earnings -15.82M; profit margin -21.55%30 Jun 2026

31 Dec 2025 ■ Revenue 322.20M ■ Earnings -196.37M — Profit margin -60.95%

-294.85M-61.9%44.36M-38.3%383.56M-14.7%722.77M8.9%31 Dec 2022: revenue 440.52M; earnings 34.58M; profit margin 7.85%31 Dec 202231 Dec 2023: revenue 624.29M; earnings 10.05M; profit margin 1.61%31 Dec 202331 Dec 2024: revenue 616.56M; earnings 13.36M; profit margin 2.17%31 Dec 202431 Dec 2025: revenue 322.20M; earnings -196.37M; profit margin -60.95%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$0.25(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$0.25High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning DCGO

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-206.39M
Profit margin
-70.03%
Return on assets · 12 month
-69.37%
Index membership
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
681.75K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
2.79%*
Total return · month
-7.54%*
Total return · quarter
-30.08%*
Total return · half year
-37.32%*
Total return · year to date
-58.69%*
Total return · 1 year
-73.65%*
Total return · 3 years
-93.18%*
Total return · 5 years
-96.35%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$294.72M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
0.17%*
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

DocGo Inc. Overview

View more →

(m)

(m)

SEC CIK
1822359
Industry (SIC)
8000 Services-Health Services
Country of operation
United States
Business address
685 THIRD AVENUE, 9TH FLOOR, NEW YORK, New York, 10017, United States
Fiscal year end
1231
Phone
(844) 443-6246

Similar stocks

Stock NameCountryMarket CapPE Ratio
VSEE HEALTH, INC. (VSEE)United States$0.003B
Agape ATP Corp (ATPC)$0.002B
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
InnovAge Holding Corp. (INNV)United States$1.206B-635.60
Omada Health, Inc. (OMDA)United States$1.207B309.08
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Pennant Group, Inc. (PNTG)United States$1.386B39.84
Privia Health Group, Inc. (PRVA)United States$2.477B115.52
GeneDx Holdings Corp. (WGS)United States$2.638B-19.23
LifeStance Health Group, Inc. (LFST)United States$4.510B80.86